(AKTX) Akari Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Akari Therapeutics | (AKTX) share price targets
Complete technical analysis of Akari Therapeutics (AKTX) by charts plus indicators, forecast predictions and share price targets for Akari Therapeutics (AKTX)
Akari Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2026-01-29 View latest technical analysis
10 day averaged volume of Akari Therapeutics is 420620
| Date | Daily Closing Price | Open | High | Low | Volume |
| 29 Thu Jan 2026 | 0.23 | 0.25 | 0.26 | 0.23 | 1.438 times |
| 28 Wed Jan 2026 | 0.26 | 0.29 | 0.32 | 0.25 | 0.988 times |
| 27 Tue Jan 2026 | 0.27 | 0.27 | 0.28 | 0.26 | 1.217 times |
| 26 Mon Jan 2026 | 0.27 | 0.30 | 0.33 | 0.24 | 2.593 times |
| 23 Fri Jan 2026 | 0.27 | 0.28 | 0.28 | 0.25 | 0.965 times |
| 22 Thu Jan 2026 | 0.27 | 0.25 | 0.28 | 0.25 | 1.191 times |
| 21 Wed Jan 2026 | 0.26 | 0.27 | 0.27 | 0.25 | 0.589 times |
| 20 Tue Jan 2026 | 0.26 | 0.28 | 0.30 | 0.26 | 0.205 times |
| 16 Fri Jan 2026 | 0.28 | 0.27 | 0.31 | 0.27 | 0.732 times |
| 15 Thu Jan 2026 | 0.27 | 0.27 | 0.28 | 0.26 | 0.951 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 0.2, for a target of 0.3 or 0.27
Share price targets for Akari Therapeutics (AKTX)
| Target Type | Value |
| Downside Target | 0.22 |
| Downside Target | 0.23 |
| Upside Target | 0.25 |
| Upside Target | 0.26 |
| Upside Target | 0.27 |
| Upside Target | 0.30 |
| Upside Target | 0.31 |
| Upside Target | 0.32 |
| Upside Target | 0.33 |
| Upside Target | 0.42 |
| Upside Target | 0.57 |
| Upside Target | 0.60 |
| Upside Target | 0.70 |
| Upside Target | 0.84 |
| Upside Target | 1.11 |
| Upside Target | 1.24 |
Intraday share price targets for Akari Therapeutics (AKTX)
| Target Type | Value |
| Downside Intraday Target | 0.2 |
| Downside Intraday Target | 0.16 |
| Upside Intraday Target | 0.3 |
| Upside Intraday Target | 0.36 |
| Upside Intraday Target | 0.26 |
Weekly technical analysis of Akari Therapeutics (AKTX)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 29 Thu Jan 2026 | 0.23 | 0.30 | 0.33 | 0.23 | 2.114 times |
| 23 Fri Jan 2026 | 0.27 | 0.28 | 0.30 | 0.25 | 0.852 times |
| 16 Fri Jan 2026 | 0.28 | 0.29 | 0.31 | 0.26 | 0.68 times |
| 09 Fri Jan 2026 | 0.28 | 0.32 | 0.32 | 0.27 | 0.731 times |
| 02 Fri Jan 2026 | 0.29 | 0.27 | 0.31 | 0.23 | 0.584 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Akari Therapeutics (AKTX)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 29 Thu Jan 2026 | 0.23 | 0.29 | 0.33 | 0.23 | 0.15 times |
| 31 Wed Dec 2025 | 0.29 | 0.48 | 0.60 | 0.22 | 14.356 times |
| 28 Fri Nov 2025 | 0.49 | 0.78 | 0.84 | 0.42 | 1.311 times |
| 31 Fri Oct 2025 | 0.75 | 0.99 | 1.11 | 0.70 | 0.281 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Akari Therapeutics (AKTX)
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Akari Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Akari Therapeutics in short term but the buy signal is initial and weak.
Akari Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Akari Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Akari Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.26 and Akari Therapeutics (AKTX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Akari Therapeutics (AKTX) stock. Volume based technical analysis of Akari Therapeutics (AKTX) stock is negative.
Akari Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Akari Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Akari Therapeutics in short term but the buy signal is initial and weak.
Akari Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Akari Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Akari Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.26 and Akari Therapeutics (AKTX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Akari Therapeutics (AKTX) stock. Volume based technical analysis of Akari Therapeutics (AKTX) stock is negative.
Akari Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

